Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer

Author:

Wang Wen-Jing12,Gao Lixin34,Wang Simei52,Huang Wensi52,Meng Xin-Yu12,Hu Hao1ORCID,Chen Ziqiang52,Sun Jingya5,Yuan Yali6,Zhou Yubo327,Diao Xingxing52ORCID,Huang Ruimin52ORCID,Li Jia26789,Chen Xiao-Hua128ORCID

Affiliation:

1. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2. University of Chinese Academy of Sciences, Beijing 100049, China

3. The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

4. School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China

5. Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

6. School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China

7. Zhongshan Institute for Drug Discovery, The Institutes of Drug Discovery and Development, CAS, Zhongshan 528400, China

8. School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China

9. State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Publisher

American Chemical Society (ACS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3